Rock Springs Capital Management LP 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:10 pm Purchase | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | Rock Springs Capital Management LP | 3,681,174 5.960% | 595,147 (+19.29%) | Filing |
| 2023-02-14 2:54 pm Purchase | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Rock Springs Capital Management LP | 3,086,027 7.640% | 633,390 (+25.82%) | Filing |
| 2022-04-25 3:05 pm Purchase | 2022-04-14 | 13G | Inozyme Pharma, Inc. INZY | Rock Springs Capital Management LP | 2,452,637 6.120% | 2,452,637 (New Position) | Filing |